Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users

Journal of Cutaneous Medicine and Surgery
Arvin IghaniMorris F Manolson

Abstract

There is ongoing development of new therapies for psoriasis, including biologic and systemic agents such as interleukin-17, interleukin-23, and phosphodiesterase-4 inhibitors. The development of these agents has changed the landscape of psoriasis treatment options. The objective of this study was to characterize the impact of newer biologic and systemic agents approved by June 2016 on patient outcomes. We sought to evaluate and compare biologic users and nonbiologic systemic users with respect to their treatment awareness and satisfaction. We conducted a national Canadian survey from July to September 2016 on adult patients with moderate-to-severe psoriasis using biologic agents or nonbiologic systemic agents as their current primary treatment modality. Patients were asked to evaluate their overall satisfaction with their treatment agent and their awareness of other treatment options. Responses from biologic and nonbiologic systemic users were compared. Overall, 343 participants were included (biologic users: n = 218; nonbiologic users: n = 125). Treatment satisfaction: Biologic users had a higher overall satisfaction score than nonbiologic users ( P < .001). Among nonbiologic agents, apremilast (62%) was associated with the hi...Continue Reading

References

Jun 26, 2001·Clinical and Experimental Dermatology·E Christophers
Oct 19, 2001·Journal of the American Academy of Dermatology·M Lebwohl, S Ali
Nov 13, 2001·The British Journal of Dermatology·C RenziM Braga
Sep 28, 2002·BMJ : British Medical Journal·Peter Maguire, Carolyn Pitceathly
Sep 13, 2006·The British Journal of Dermatology·L DubertretUNKNOWN EUROPSO Patient Survey Group
Oct 3, 2006·Journal of the American Academy of Dermatology·Katherine K BrownAlexa B Kimball
Jan 20, 2010·Archives of Dermatology·Vivianne Beyer, Stephen E Wolverton
Mar 17, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·C PaulJ-P Ortonne
Apr 12, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
Jun 9, 2012·Acta Dermato-venereologica·Francesca SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators
Apr 10, 2013·The British Journal of Dermatology·O D van CranenburghE M A Smets
Nov 15, 2014·Acta Dermato-venereologica·Marthe-Lisa SchaarschmidtWiebke K Peitsch
Dec 3, 2014·Actas dermo-sifiliográficas·T Torres, L Puig
May 31, 2015·Lancet·Wolf-Henning Boehncke, Michael P Schön
Jan 28, 2018·Journal of Cutaneous Medicine and Surgery·Arvin IghaniJensen Yeung

❮ Previous
Next ❯

Software Mentioned

JCMS
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
C E M GriffithsACCEPT Study Group
Journal of Drugs in Dermatology : JDD
Jessica PriceRajesh Balkrishnan
Clinical, Cosmetic and Investigational Dermatology
Jennifer D BahnerNeil J Korman
© 2022 Meta ULC. All rights reserved